Historical record - last NADAC publication: 1/4/2017

Product Information

AFINITOR 10 MG TABLET is a brand product labeled by Novartis Pharmaceuticals Corporation, priced at $462.0394 per EA under NDC 00078056751. Its NADAC has been published 164 times since Nov 28, 2013.

The High Outlier badge above means this manufacturer's average price in the everolimus market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

AFINITOR 10 MG TABLET

everolimus
$462.0394per EA
High Outlier

Strength

10 mg/1

NDC

00078056751

Classification

Brand

Dosage Form

TABLET

Route

ORAL

Last Updated

1/4/2017

Active Ingredients

EVEROLIMUS

Approval Type

New Drug (NDA)

FDA Application

NDA022334

On Market Since

3/31/2009

Pharmacological Classes

Cytochrome P450 2D6 Inhibitors
Cytochrome P450 3A4 Inhibitors
Decreased Immunologic Activity
Kinase Inhibitor
Protein Kinase Inhibitors
mTOR Inhibitor Immunosuppressant
mTOR Inhibitors

Price Statistics

The NADAC for AFINITOR 10 MG TABLET has been published 164 times since Nov 28, 2013, and over the history we have for it it has risen 54.8%. The table below summarizes its recorded NADAC range and movement.

Current price$462.0394 per EA
All-time high$462.0394 (Jan 11, 2017)
All-time low$298.5211 (Nov 28, 2013)
Median price$378.2212
Average price$375.5271
Largest weekly change+9.9% (Jan 15, 2014)
Weeks tracked164
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

0.0%

5Y

0.0%

All

+54.8%

Generic Alternatives

The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 94% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of AFINITOR 10 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for AFINITOR 10 MG TABLET, manufactured by Novartis Pharmaceuticals Corporation, is $462.0394 per EA (NDC 00078056751), effective Jan 11, 2017.

How has the price of AFINITOR 10 MG TABLET changed over time?

Over the history we have for it, the NADAC for AFINITOR 10 MG TABLET has risen 54.8%. It has been tracked across 164 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for AFINITOR 10 MG TABLET?

Since Nov 28, 2013, the NADAC for AFINITOR 10 MG TABLET has ranged from a low of $298.5211 (Nov 28, 2013) to a high of $462.0394 (Jan 11, 2017), with a median of $378.2212 per EA.

Are there cheaper alternatives to AFINITOR 10 MG TABLET?

Yes. 2 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, EVEROLIMUS 10 MG TABLET, is $26.3242 per EA — about 94% below AFINITOR 10 MG TABLET.

Who manufactures AFINITOR 10 MG TABLET?

AFINITOR 10 MG TABLET (NDC 00078056751) is labeled by Novartis Pharmaceuticals Corporation, and CMS classifies it as a brand product.